Above, Dr. Donald Weaver, Director of Toronto Western Research Institute, looks out from the Krembil Discovery Tower. In 2007, Weaver won the U.S. Centennial Award for being “one of the two researchers in the world with the highest likelihood of discovering a ‘curative’ drug for Alzheimer’s”. (Photo: Research Communications)
The countdown is on – the Krembil Discovery Tower is set to open on Wednesday, Nov. 20.
Here’s why it’s important:
The Krembil Discovery Tower (KDT) brings together some of the world’s top researchers who are working to find cures for some of the most prevalent chronic diseases.
KDT is part of University Health Network’s Toronto Western Hospital.
Finding a cure for Alzheimer’s disease is just one of the missions KDT researchers will be tackling. It's crucial for many reasons:
Currently, an estimated 500,000 Canadians have Alzheimer’s disease or a related dementiaIn just five years, as many as 50 per cent more Canadians and their families could face the conditionWithin a generation, the number of Canadians with Alzheimer's disease or a related dementia will more than double
World leading expert
Dr. Donald Weaver, Director of the Toronto Western Research Institute, is one of the researchers at KDT whose goal is to cure Alzheimer’s disease, one of the most common forms of dementia. In 2007, Weaver won the U.S. Centennial Award for being “one of the two researchers in the world with the highest likelihood of discovering a ‘curative’ drug for Alzheimer’s”.
This week UHN.ca will share stories showcasing some of the research within KDT, so check in daily. Until then – test your knowledge by clicking on our poll question below.
Test your knowledge
